Trump’s Eli Lilly Purchases Coincided With GLP-1 Policy Developments<\/p>\n
Citing disclosure forms signed by Trump, KFF Health News reported <\/a>seven purchases of Eli Lilly shares through the end of March. The first transaction occurred on January 6, according to the filings.<\/p>\n The company, valued at nearly $1 trillion by the market, has become a major player in the growing GLP-1 weight-loss drug market.<\/p>\n The timing of the investments aligned with several administration initiatives tied to Medicare coverage of obesity treatments<\/a>.<\/p>\n The proposed initiative was viewed as a temporary bridge program that could later lead to permanent Medicare reimbursement for weight-loss treatments. Drugmakers were required to submit applications for participation by January 8.<\/p>\n Eli Lilly was later named as one of the participating manufacturers in the program. The company described the inclusion as a “significant milestone” for its obesity treatment business.<\/p>\n West Pharmaceutical Investment Also Tied To GLP-1 Market<\/p>\n West Pharmaceutical manufactures injectable delivery systems used in drug treatments and recently cited growth in its GLP-1 segment as a contributor to higher quarterly revenue<\/a>.<\/p>\n Trump Organization Says Investments Are Independently Managed<\/p>\n A spokesperson for the Trump Organization told Reuters that Trump’s investment holdings are maintained through discretionary accounts managed independently by third-party financial institutions.<\/p>\n According to the statement, trading decisions and portfolio balancing are handled through automated systems controlled by those firms.<\/p>\n According to Reuters, the \u200bpresident’s assets are held in a trust controlled by his children.<\/p>\n LLY Price Action:<\/strong> Eli Lilly shares were up 2.73% at $1015.09 at the time of publication on Tuesday, according to Benzinga Pro data<\/a>.<\/p>\n Over the past month, LLY has gained about 9.4% versus a 3.9% rise in the S&P 500 and is down roughly 6% year-to-date compared to the index’s 7.4% gain.<\/p>\n Image via Shutterstock<\/p>\n